Literature DB >> 30166998

Incidence and predictors of 30-day mortality in patients with ventricular septal rupture complicating acute myocardial infarction.

Akshyaya Pradhan1, Nirdesh Jain1, Salvatore Cassese2, Pravesh Vishwakarma1, Rishi Sethi1, Sharad Chandra1, Gaurav Chaudhary1, Sudhanshu Kumar Dwivedi1, Varun Shankar Narain1.   

Abstract

OBJECTIVE: We sought to investigate the incidence and predictors of 30-day mortality associated with ventricular septal rupture (VSR) complicating acute myocardial infarction (AMI) in a cohort of patients admitted to a single centre in India.
METHODS: From October 2013 to February 2016, a total of 6560 patients with a diagnosis of AMI were admitted to our institution. Among these patients, those with a diagnosis of VSR were retrospectively included in this registry. Clinical and echocardiographic features were collected in all cases. The primary outcome was 30-day mortality. A Cox proportional hazard regression analysis explored the predictors of 30-day mortality.
RESULTS: During the observation period, a total of 51 consecutive patients (mean age 63.8 years (9.1); 51.0% male, 41.2% were patients with diabetes) with a diagnosis of VSR complicating AMI were included. On echocardiography, left ventricular ejection fraction was 42.5% (6.5), and the most frequent location of VSR was apical (78.4%). Overall, 27.4% of the patients received reperfusive therapy (pharmacological, 23.5%; mechanical, 3.9%) and 19.6% of the patients underwent surgical repair. The mean time to surgery was 7.7 days (2.4). At 30-day follow-up, death occurred in 80.4% of patients. Advanced age (HR 1.07, 95% CI (1.02 to 1.13), p=0.004), previous cerebrovascular accident (HR 52.2, 95% CI (3.98 to 685.06), p=0.003) and surgical repair (HR 0.05, 95% CI (0.01 to 0.26), p<0.001) were effect modifiers of the 30-day risk of death.
CONCLUSIONS: In this retrospective cohort of patients with AMI, the occurrence of VSR was not rare and carried a considerable risk of 30-day mortality. Advanced age, previous cerebrovascular accident and surgical repair influenced the risk for 30-day mortality.

Entities:  

Keywords:  acute myocardial infarction; mortality; registry; surgery; ventricular septal rupture

Year:  2018        PMID: 30166998      PMCID: PMC6109810          DOI: 10.1136/heartasia-2018-011062

Source DB:  PubMed          Journal:  Heart Asia        ISSN: 1759-1104


  17 in total

Review 1.  Ventricular septal rupture after acute myocardial infarction.

Authors:  Yochai Birnbaum; Michael C Fishbein; Carlos Blanche; Robert J Siegel
Journal:  N Engl J Med       Date:  2002-10-31       Impact factor: 91.245

2.  Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial.

Authors:  Paul W Armstrong; Christopher B Granger; Peter X Adams; Christian Hamm; David Holmes; William W O'Neill; Thomas G Todaro; Alec Vahanian; Frans Van de Werf
Journal:  JAMA       Date:  2007-01-03       Impact factor: 56.272

3.  Mechanical complications after percutaneous coronary intervention in ST-elevation myocardial infarction (from APEX-AMI).

Authors:  John K French; Anne S Hellkamp; Paul W Armstrong; Eric Cohen; Neil S Kleiman; Christopher M O'Connor; David R Holmes; Judith S Hochman; Christopher B Granger; Kenneth W Mahaffey
Journal:  Am J Cardiol       Date:  2010-01-01       Impact factor: 2.778

Review 4.  Ventricular septal rupture complicating acute myocardial infarction: a contemporary review.

Authors:  Brandon M Jones; Samir R Kapadia; Nicholas G Smedira; Michael Robich; E Murat Tuzcu; Venu Menon; Amar Krishnaswamy
Journal:  Eur Heart J       Date:  2014-06-26       Impact factor: 29.983

5.  Precision in cardiology: should all cases of myocardial infarction with ventricular septal rupture require early repair?

Authors:  Yash Paul Sharma; Naveen Krishna Kamana; Ramalingam Vadivelu
Journal:  Heart Asia       Date:  2013-11-19

Review 6.  What is the best timing of surgery in patients with post-infarct ventricular septal rupture?

Authors:  Niovi Papalexopoulou; Christopher P Young; Rizwan Q Attia
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-11-09

Review 7.  Commonalities of cardiac rupture (left ventricular free wall or ventricular septum or papillary muscle) during acute myocardial infarction secondary to atherosclerotic coronary artery disease.

Authors:  William C Roberts; Kendall H Burks; Jong Mi Ko; Giovanni Filardo; Joseph M Guileyardo
Journal:  Am J Cardiol       Date:  2014-10-13       Impact factor: 2.778

8.  Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?

Authors:  V Menon; J G Webb; L D Hillis; L A Sleeper; R Abboud; V Dzavik; J N Slater; R Forman; E S Monrad; J D Talley; J S Hochman
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

9.  Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data.

Authors:  Denis Xavier; Prem Pais; P J Devereaux; Changchun Xie; D Prabhakaran; K Srinath Reddy; Rajeev Gupta; Prashant Joshi; Prafulla Kerkar; S Thanikachalam; K K Haridas; T M Jaison; Sudhir Naik; A K Maity; Salim Yusuf
Journal:  Lancet       Date:  2008-04-26       Impact factor: 79.321

Review 10.  Cardiovascular disease and risk factors in Asia: a selected review.

Authors:  Hirotsugu Ueshima; Akira Sekikawa; Katsuyuki Miura; Tanvir Chowdhury Turin; Naoyuki Takashima; Yoshikuni Kita; Makoto Watanabe; Aya Kadota; Nagako Okuda; Takashi Kadowaki; Yasuyuki Nakamura; Tomonori Okamura
Journal:  Circulation       Date:  2008-12-16       Impact factor: 29.690

View more
  1 in total

1.  One-year outcome and survival analysis of deferred ventricular septal repair in cardiogenic shock supported with mechanical circulatory support.

Authors:  Jahanzeb Malik; Faizan Younus; Asmara Malik; Muhammad Umar Farooq; Ahmed Kamal; Muhammad Shoaib; Hesham Naeem; Ghazanfar Rana; Abdul Sattar Rana; Muhammad Usman; Shahid Khalil
Journal:  PLoS One       Date:  2021-08-18       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.